Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia

Metzgeroth, G. and Schwaab, J. and Naumann, N. and Haferlach, C. and Jawhar, M. and Horny, H. -P. and Dirk, J. and Kratz-Albers, K. and Kraemer, D. and Mayer, S. and Storch, N. and Burchert, A. and Haferlach, T. and Cross, N. C. P. and Hofmann, W. -K. and Fabarius, A. and Reiter, A. (2017) Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia. ONCOLOGY RESEARCH AND TREATMENT, 40 (Suppl3). p. 196. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Dec 2018 13:15
Last Modified: 17 Sep 2020 06:32
URI: https://pred.uni-regensburg.de/id/eprint/1261

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.